AOA Dx News Exclusive: Liquid-biopsy startup closes $17M to fund ovarian cancer diagnostic test
Liquid biopsy startup AOA Dx has collected $17 million to support the development of its diagnostic test for ovarian cancer...
AOA Dx News Exclusive: Liquid-biopsy startup closes $17M to fund ovarian cancer diagnostic test
AMWELL Enhances Virtual Care Platform with Two Acquisitions: SilverCloud Health and Conversa Health
The Silicon Review names Conversa as one of the 50 Fastest Growing Companies in the Year 2021
Eirion Therapeutics, Inc. Closes $40 Million Series A Investment and Licensing Deal
Automated Virtual Care Platform Conversa Health Expands Series B to $20 Million
Maternity management company Dorsata scores $5.2M in Series A funding
Or-Genix Therapeutics Inc. and Fission Labs Announce Partnership for LATAM Dermatology Markets
Castle Biosciences Announces Pricing of Initial Public Offering
Cristina Griffin Joins Or-Genix Therapeutics as Chief Business Officer
Genomic diagnostics provider Castle Biosciences files for a $58 million IPO